Sausville EA - Search Results

1

Characterization of anticancer agents by their growth inhibitory activity and relationships to mechanism of action and structure.

Keskin O, Bahar I, Jernigan RL, Beutler JA, Shoemaker RH, Sausville EA, Covell DG. Keskin O, et al. Among authors: sausville ea. Anticancer Drug Des. 2000 Apr;15(2):79-98. Anticancer Drug Des. 2000. PMID: 10901296

2

Linking the growth inhibition response from the National Cancer Institute's anticancer screen to gene expression levels and other molecular target data.

Wallqvist A, Rabow AA, Shoemaker RH, Sausville EA, Covell DG. Wallqvist A, et al. Among authors: sausville ea. Bioinformatics. 2003 Nov 22;19(17):2212-24. doi: 10.1093/bioinformatics/btg302. Bioinformatics. 2003. PMID: 14630650

3

Mining the National Cancer Institute's tumor-screening database: identification of compounds with similar cellular activities.

Rabow AA, Shoemaker RH, Sausville EA, Covell DG. Rabow AA, et al. Among authors: sausville ea. J Med Chem. 2002 Feb 14;45(4):818-40. doi: 10.1021/jm010385b. J Med Chem. 2002. PMID: 11831894

4

Application of high-throughput, molecular-targeted screening to anticancer drug discovery.

Shoemaker RH, Scudiero DA, Melillo G, Currens MJ, Monks AP, Rabow AA, Covell DG, Sausville EA. Shoemaker RH, et al. Among authors: sausville ea. Curr Top Med Chem. 2002 Mar;2(3):229-46. doi: 10.2174/1568026023394317. Curr Top Med Chem. 2002. PMID: 11944818 Review.

5

Establishing connections between microarray expression data and chemotherapeutic cancer pharmacology.

Wallqvist A, Rabow AA, Shoemaker RH, Sausville EA, Covell DG. Wallqvist A, et al. Among authors: sausville ea. Mol Cancer Ther. 2002 Mar;1(5):311-20. Mol Cancer Ther. 2002. PMID: 12489847

6

In vivo models for experimental therapeutics relevant to human cancer.

Gitler MS, Sausville EA, Hollingshead M, Shoemaker R. Gitler MS, et al. Among authors: sausville ea. Cancer Res. 2004 Nov 15;64(22):8478-80. doi: 10.1158/0008-5472.CAN-04-2057. Cancer Res. 2004. PMID: 15548722 No abstract available.

7

Differential gene expression as a potential classifier of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole-sensitive and -insensitive cell lines.

Wallqvist A, Connelly J, Sausville EA, Covell DG, Monks A. Wallqvist A, et al. Among authors: sausville ea. Mol Pharmacol. 2006 Mar;69(3):737-48. doi: 10.1124/mol.105.017061. Epub 2005 Dec 6. Mol Pharmacol. 2006. PMID: 16332985

8

Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.

Rapisarda A, Uranchimeg B, Scudiero DA, Selby M, Sausville EA, Shoemaker RH, Melillo G. Rapisarda A, et al. Among authors: sausville ea. Cancer Res. 2002 Aug 1;62(15):4316-24. Cancer Res. 2002. PMID: 12154035

9

Cytotoxicity of RH1: NAD(P)H:quinone acceptor oxidoreductase (NQO1)-independent oxidative stress and apoptosis induction.

Tudor G, Alley M, Nelson CM, Huang R, Covell DG, Gutierrez P, Sausville EA. Tudor G, et al. Among authors: sausville ea. Anticancer Drugs. 2005 Apr;16(4):381-91. doi: 10.1097/00001813-200504000-00004. Anticancer Drugs. 2005. PMID: 15746574

10

Role of the National Cancer Institute in acquired immunodeficiency syndrome-related drug discovery.

Sausville EA, Shoemaker RH. Sausville EA, et al. J Natl Cancer Inst Monogr. 2001;(28):55-7. doi: 10.1093/oxfordjournals.jncimonographs.a024259. J Natl Cancer Inst Monogr. 2001. PMID: 11158208 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters